In Vitro Diagnostic
Table of Contents
examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. BioMerieux is a part of the Institut Merieux group. The industry player is engaged in providing in-vitro diagnostics for medical and industrial applications. The industry player designs, develops, manufactures and industry s systems used in clinical applications, such as for the diagnosi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
ContraFect Corporation - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “ContraFect Corporation - Product Pipeline Review - 2013” provides data on the ContraFect ...
GeNeuro SA - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “GeNeuro SA - Product Pipeline Review - 2013” provides data on the GeNeuro SA's research and development ...
Summary Xhale, Inc. (Xhale) is a medical device company. The company develops non invasive medical devices for the diagnostic market. Its products include pharmaceutical supply chain integrity, therapeutic ...
... Was successfully commercialized in japan. 1961 Establishment of clinical laboratory division. Initiation of r&d of clinical diagnostics. 1969 Company name was changed to eiken chemical co., Ltd. In recognition ...
... Laboratory (r&d) automation is a steady growing market. molecular diagnostic market s trend clinical medical pss business field & strategy 7 products sales in business segment mid-term business plan ...
... In dna-based testing services for developmental disorders and cancer diagnostics, reported today that total revenues for the fourth quarter and twelve months ended december 31, 2013 increased to $1 ...
Reportlinker.com © Copyright 2014. All rights reserved.